Hui Ping Jiang
General Counsel bei VALERIO THERAPEUTICS
Ursprung des Netzwerks ersten Grades von Hui Ping Jiang
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hui Ping Jiang
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Aventis, Inc. | Comptroller/Controller/Auditor | ||
SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Corporate Officer/Principal | |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Investment Managers | Director/Board Member | |
Chevrillon & Associés SCA
Chevrillon & Associés SCA Investment ManagersFinance Chevrillon & Associés SCA is an Independent Private Equity firm founded in 1992 by Cyrille Chevrillon and Jean Nicolas Trebouta. Chevrillon & Associés SCA is headquartered in Paris, France. | Investment Managers | Founder | |
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Pharmaceuticals: Major | President | |
Aster
Aster SteelNon-Energy Minerals Part of ArcelorMittal SA, Aster is a French company that manufactures steel. | Steel | Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Graduate Degree | |
Georgetown University | College/University | Undergraduate Degree | |
TECHNOFLEX | Chemicals: Major Diversified | Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree | |
Karnataka University | College/University | Doctorate Degree | |
University of Texas Health Center | College/University | Corporate Officer/Principal | |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
AlchiMedics SA
AlchiMedics SA Chemicals: Major DiversifiedProcess Industries AlchiMedics SA specializes in coating technologies via electrografting. Its products enables covalent adhesion of nano to micrometric polymer-based layers on surfaces. The firm designs, develops and implements electro-grafting technology for implantable biomedical applications. The company was founded in 2007 and is headquartered in Grenoble, France. | Chemicals: Major Diversified | Director/Board Member | |
EPIZYME, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CARMAT | Medical Specialties | Investor Relations Contact | |
Financière de la Montagne SARL
Financière de la Montagne SARL Financial ConglomeratesFinance Financière de la Montagne provides financial management services. The firm also provides investment consulting services. The company is headquartered in Paris, France. | Financial Conglomerates | Corporate Officer/Principal | |
Alcami Carolinas Corp.
Alcami Carolinas Corp. Pharmaceuticals: MajorHealth Technology Alcami Carolinas Corp. operates as a pharmaceutical development and manufacturing company. It offers development, biopharmaceutical, and analytical testing services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Pharmaceuticals: Major | Director of Finance/CFO | |
EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member | |
Valois SAS
Valois SAS Industrial MachineryProducer Manufacturing Valois SAS provides spray, aerosol and lotion dispensing systems. The company was founded in 1947 and is headquartered in Le Neubourg, France. | Industrial Machinery | Corporate Officer/Principal | |
SENSORION | Pharmaceuticals: Major | Chairman Director/Board Member | |
Isocell SA
Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Food Retail | Director/Board Member | |
École des Hautes Études Commerciales du Nord | College/University | Graduate Degree | |
Institut d'Administration des Entreprises de Paris | College/University | Graduate Degree | |
Invus SAS (Investment Management)
Invus SAS (Investment Management) Investment ManagersFinance Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies. | Investment Managers | Analyst-Equity | |
mAbRx, Inc.
mAbRx, Inc. Medical/Nursing ServicesHealth Services mAbRx, Inc. provides physician services. The private company is based in Wilmington, NC. The company was founded by Philippe M. Maitre. | Medical/Nursing Services | Founder | |
GRITSTONE BIO, INC. | Biotechnology | Director/Board Member | |
Onxeo US | Chief Operating Officer | ||
PPD, INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
SCI du Chardonnet
SCI du Chardonnet Real Estate DevelopmentFinance SCI du Chardonnet provides real estate services. The private company is based in Paris, France. | Real Estate Development | Corporate Officer/Principal | |
Fleurus Immobilier SCI | Corporate Officer/Principal | ||
SCI 5 Rue de la Liberté | Chairman | ||
GIE IO | Director/Board Member | ||
EARL Ferme de Bissy | Corporate Officer/Principal | ||
SCI du Trillon | Corporate Officer/Principal | ||
Centre Detudes Litteraires Et Scientifiques Appliquees | College/University | Graduate Degree | |
Merrick School of Business | College/University | Graduate Degree |
Statistik
International
Frankreich | 25 |
Vereinigte Staaten | 23 |
Schweiz | 3 |
Schweden | 2 |
Indien | 2 |
Sektoral
Health Technology | 14 |
Consumer Services | 10 |
Finance | 9 |
Commercial Services | 6 |
Process Industries | 3 |
Operativ
Director/Board Member | 29 |
Corporate Officer/Principal | 14 |
Independent Dir/Board Member | 11 |
Director of Finance/CFO | 5 |
Chairman | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hui Ping Jiang
- Unternehmensverbindungen